September 8, 2021
Nashville site will deliver on strategy to enable reliable supply of critical materials used to produce new biologics and vaccines WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced plans to establish a manufacturing facility in Nashville dedicated to the production of single-use technologies (SUT) products. This investment [...]
September 8, 2021
Delivers expanded heme-onc menu and the ability to analyze low-input samples SOUTH SAN FRANCISCO -- Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced two key improvements to the core capabilities of its Tapestri Platform intended to expand its accessibility and utility in the area of hematologic oncology (heme-onc) research. These [...]
September 8, 2021
MOUNTAIN VIEW, Calif. -- DNAnexus, Inc., the leading cloud-based biomedical and data management platform for healthcare and life sciences, today announced the appointment of Asha S. Collins, PhD, to General Manager, Biobanks. Dr. Collins will be responsible for managing the UK Biobank project and supporting the company’s diverse global health research community. She will report [...]
September 8, 2021
Fremont, CA -- Alamar Biosciences, Inc., a precision proteomics company that brings both ultra-high sensitivity and massively parallel scale to proteomic analysis, announced today that it has closed its $80 million Series B financing round, bringing its total funding to $110 million. The Series B financing round was led by Sherpa Healthcare Partners and included [...]
Next-Generation Nano-, Capillary- and Micro-Flow LC Systems Enhance Productivity and Performance
September 8, 2021
Thermo Scientific Vanquish Neo UHPLC System and Thermo Scientific PepMap Neo Columns enable consistent, high-quality results in high-sensitivity LC-MS workflows GERMERING, Germany -- Principal investigators, laboratories, and proteomics researchers in academia, biopharma and contract research organizations can now benefit from an all-in-one nano-, capillary- and micro-flow liquid chromatography (LC) system. Designed for high sensitivity LC-mass spectrometry (LC-MS) applications, [...]
September 7, 2021
SAN DIEGO and SHANGHAI, China -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, has adopted Bionano’s Saphyr system for optical genome mapping (OGM) to integrate their Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA) technologies for research and product [...]
Agilent Announces Thought Leader Award to David R. Liu at the Broad Institute
September 7, 2021
Researcher recognized for influential work on genome editing and CRISPR applications SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced Dr. David R. Liu has been selected to receive a prestigious Agilent Thought Leader Award. A prominent researcher in the field of genome editing, Dr. Liu is Professor and Director of the Merkin Institute of Transformative Technologies [...]
ENPICOM introduces a powerful liability prediction solution to de-risk antibody development
September 7, 2021
The IGX Platform empowers researchers to accurately predict exposed liabilities for thousands of sequences at the same time using high-throughput structural modeling ‘s-Hertogenbosch, The Netherlands – Life Science Newswire – ENPICOM, an innovative bioinformatics software company, announced today at the Biologics UK conference new IGX Platform capabilities to accurately annotate exposed liabilities, perform structural modeling [...]
September 7, 2021
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) and Merck (known as MSD outside the United States and Canada) today announced a partnership to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency (HRD). Patients whose tumors are HRD-positive may be eligible for targeted treatment by a class of [...]
September 7, 2021
SCOTTSDALE, Ariz. -- INanoBio, a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine learning, today announced it has successfully fabricated initial prototypes of its novel Field Effect Nanopore Transistor (FENT) device. FENT is INanoBio’s proprietary technology, a revolutionary device that combines CMOS transistor technology with solid state nanopores for [...]

